Form 4: Viemed Healthcare Director Smokoff Receives 15,732 Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Timothy Smokoff received 15,732 Restricted Stock Units (RSUs) from Viemed Healthcare, vesting on August 20, 2025.

Summary

  • On August 20, 2024, Timothy Smokoff, a director of Viemed Healthcare, Inc., was granted 15,732 Restricted Stock Units (RSUs).
  • Each RSU represents the right to receive one common share of Viemed Healthcare.
  • The RSUs vest on August 20, 2025.
  • Smokoff can defer delivery of the common shares until separation from service or a specified date within 10 years of the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of RSUs is a standard practice and indicates confidence in the company's future performance. It aligns the director's interests with shareholders.

Positives

  • The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing him to work towards the company's success.
  • The vesting period of one year suggests a commitment to the company's long-term performance.

Industry Context

Grants of restricted stock units are a common form of executive compensation in the healthcare industry, aligning management's interests with those of shareholders.

Stakeholder Impact

  • Shareholders may view the RSU grant positively as it aligns management's interests with theirs.
  • Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

DateDescription
08/20/2024Date of the RSU grant to Timothy Smokoff.
08/20/2025Vesting date of the granted RSUs.
08/22/2024Date of the form filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.